94 related articles for article (PubMed ID: 16503420)
21. OSP/claudin-11-induced EAE in mice is mediated by pathogenic T cells primarily governed by OSP192Y residue of major encephalitogenic region OSP179-207.
Kaushansky N; Hemo R; Eisenstein M; Ben-Nun A
Eur J Immunol; 2007 Jul; 37(7):2018-31. PubMed ID: 17549734
[TBL] [Abstract][Full Text] [Related]
22. Inoculation of BCL1 lymphoma cells into CSJL/J F1 mice inhibits acute experimental autoimmune encephalomyelitis.
Abramsky O; Karussis DM; Mizrachi-Koll R; Lehmann D
Isr J Med Sci; 1994 Jan; 30(1):1-6. PubMed ID: 7511133
[TBL] [Abstract][Full Text] [Related]
23. Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis.
van Zwam M; Huizinga R; Heijmans N; van Meurs M; Wierenga-Wolf AF; Melief MJ; Hintzen RQ; 't Hart BA; Amor S; Boven LA; Laman JD
J Pathol; 2009 Mar; 217(4):543-51. PubMed ID: 19023878
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide.
Karussis DM; Lehmann D; Slavin S; Vourka-Karussis U; Mizrachi-Koll R; Ovadia H; Ben-Nun A; Kalland T; Abramsky O
Ann Neurol; 1993 Nov; 34(5):654-60. PubMed ID: 8239559
[TBL] [Abstract][Full Text] [Related]
25. Protection from autoimmunity by DNA vaccination against T-cell receptor.
Buch T; Waisman A
Methods Mol Med; 2006; 127():269-80. PubMed ID: 16988460
[TBL] [Abstract][Full Text] [Related]
26. Mannosylated self-peptide inhibits the development of experimental autoimmune encephalomyelitis via expansion of nonencephalitogenic T cells.
Kel JM; Slütter B; Drijfhout JW; Koning F; Nagelkerken L
J Leukoc Biol; 2008 Jul; 84(1):182-90. PubMed ID: 18424662
[TBL] [Abstract][Full Text] [Related]
27. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation.
Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Re YD; Shi LP; Wan J; Yang YF; Yuan C; Nan FJ; Lawson BR; Zuo JP
J Pharmacol Exp Ther; 2006 Nov; 319(2):799-808. PubMed ID: 16914558
[TBL] [Abstract][Full Text] [Related]
28. Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor V beta-specific antibodies.
Zaller DM; Osman G; Kanagawa O; Hood L
J Exp Med; 1990 Jun; 171(6):1943-55. PubMed ID: 1693655
[TBL] [Abstract][Full Text] [Related]
29. CD44 variant DNA vaccination with virtual lymph node ameliorates experimental autoimmune encephalomyelitis through the induction of apoptosis.
Garin T; Rubinstein A; Grigoriadis N; Nedvetzki S; Abramsky O; Mizrachi-Koll R; Hand C; Naor D; Karussis D
J Neurol Sci; 2007 Jul; 258(1-2):17-26. PubMed ID: 17382349
[TBL] [Abstract][Full Text] [Related]
30. Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression.
Einstein O; Fainstein N; Vaknin I; Mizrachi-Kol R; Reihartz E; Grigoriadis N; Lavon I; Baniyash M; Lassmann H; Ben-Hur T
Ann Neurol; 2007 Mar; 61(3):209-18. PubMed ID: 17187374
[TBL] [Abstract][Full Text] [Related]
31. Mice deficient in PKC theta demonstrate impaired in vivo T cell activation and protection from T cell-mediated inflammatory diseases.
Anderson K; Fitzgerald M; Dupont M; Wang T; Paz N; Dorsch M; Healy A; Xu Y; Ocain T; Schopf L; Jaffee B; Picarella D
Autoimmunity; 2006 Sep; 39(6):469-78. PubMed ID: 17060026
[TBL] [Abstract][Full Text] [Related]
32. Immunoregulation by Vbeta specific antibodies in myasthenia gravis: mining physiological T cell homeostasis for TCR specific therapy.
Jambou F; Cohen-Kaminsky S
Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):181-92. PubMed ID: 12887101
[TBL] [Abstract][Full Text] [Related]
33. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
34. Oligodendrocyte-specific protein is encephalitogenic in rhesus macaques and induces specific demyelination of the optic nerve.
Bajramovic JJ; Brok HP; Ouwerling B; Jagessar SA; van Straalen L; Kondova I; Bauer J; Amor S; 't Hart BA; Ben-Nun A
Eur J Immunol; 2008 May; 38(5):1452-64. PubMed ID: 18412169
[TBL] [Abstract][Full Text] [Related]
35. Fulminant experimental autoimmune encephalo-myelitis induced by retrovirally mediated TCR gene transfer.
Stolzer AL; Sadelain M; Sant'Angelo DB
Eur J Immunol; 2005 Jun; 35(6):1822-30. PubMed ID: 15909313
[TBL] [Abstract][Full Text] [Related]
36. The susceptibility to experimental autoimmune encephalomyelitis is not related to dysferlin-deficiency.
Hochmeister S; Bittner RE; Höger H; Lassmann H; Bradl M
Autoimmunity; 2009 Mar; 42(3):235-41. PubMed ID: 19301206
[TBL] [Abstract][Full Text] [Related]
37. Characterization of Multiple Sclerosis candidate gene expression kinetics in rat experimental autoimmune encephalomyelitis.
Thessen Hedreul M; Gillett A; Olsson T; Jagodic M; Harris RA
J Neuroimmunol; 2009 May; 210(1-2):30-9. PubMed ID: 19269041
[TBL] [Abstract][Full Text] [Related]
38. Protection against experimental autoimmune encephalomyelitis generated by a recombinant adenovirus vector expressing the V beta 8.2 TCR is disrupted by coadministration with vectors expressing either IL-4 or -10.
Braciak TA; Pedersen B; Chin J; Hsiao C; Ward ES; Maricic I; Jahng A; Graham FL; Gauldie J; Sercarz EE; Kumar V
J Immunol; 2003 Jan; 170(2):765-74. PubMed ID: 12517939
[TBL] [Abstract][Full Text] [Related]
39. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
[TBL] [Abstract][Full Text] [Related]
40. Minor role of bystander tolerance to fetal calf serum in a peptide-specific dendritic cell vaccine model against autoimmunity: comparison with serum-free cultures.
Röner S; Zinser E; Menges M; Wiethe C; Littmann L; Hänig J; Steinkasserer A; Lutz MB
J Immunother; 2008 Sep; 31(7):656-64. PubMed ID: 18600179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
